The 2016 Summit—Research Reproducibility: Innovative Solutions to Drive Quality—welcomed premiere life science thought leaders as speakers and panelists. We were joined in the conversation by top scientists and policy makers from NIH, science societies, foundations, journals and industry, and GBSI’s challenge to the bio-research community, Reproducibility2020 was introduced.
The Global Biological Standards Institute (GBSI) in conjunction with The Antibody Society brought together key stakeholders from academia, antibody producers, pharma, funders, and journals to share perspectives and contribute to tangible solutions for validating antibodies.
Our 2014 inaugural Summit focused on cancer research by recognizing the transformative impact cell authentication can have in improving cancer study replication. We shared key recommendations developed by GBSI’s Cancer Cell Authentication and Standards Task Force, including the role public and private funders can have on improving the quality and efficacy of research.
This unique, 1-day conference took place on October 1st at the Media Lab on the campus of MIT in Cambridge. The 2013 Biotechnology & Standards Conference–The Prospects for a Life Sciences Standards Revolution, brought together over 80 academic biologists, biopharma executives, economists, legal and standards experts, and policymakers.